Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)

• मुख्य लेखकों: Kathryn Kline (लेखक), Wengen Chen (लेखक), Michael E. Kallen (लेखक), Rima Koka (लेखक), Destiny Omili (लेखक), Xiaoxuan Fan (लेखक), Thierry Iraguha (लेखक), Etse Gebru (लेखक), Nishanthini Dishanthan (लेखक), Jillian M. Baker (लेखक), Kenneth A. Dietze (लेखक), Jean A. Yared (लेखक), Kim Hankey (लेखक), Saurabh Dahiya (लेखक), Silke V. Niederhaus (लेखक), Kieron Dunleavy (लेखक), Nancy M. Hardy (लेखक), Tim Luetkens (लेखक), Aaron P. Rapoport (लेखक), Djordje Atanackovic (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Taylor & Francis Group, 2023-08-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Post-transplant lymphoproliferative disorder (PTLD) is a potentially fatal complication following kidney transplantation, and there is a critical and unmet need for PTLD treatments associated with more pronounced and durable responses. To date, reports on the use of CD19-targeted chimeric antigen re...